Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants

Next Previous
X
Search
Trial Profile

Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 14 Nov 2024

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary) ; SP-0202 (Primary) ; Hepatitis B vaccine recombinant; Hib-DTaP-poliovirus vaccine; Measles mumps and rubella virus vaccine; Rotavirus vaccine; Varicella vaccines
  • Indications Diphtheria; Hepatitis B; Influenza B virus infections; Measles; Mumps; Pertussis; Pneumococcal infections; Poliomyelitis; Rubella; Tetanus; Varicella zoster virus infections
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Sanofi Pasteur

    • Most Recent Events

    • 12 Nov 2024 According to ClinicalTrials.gov by the U.S. National Institutes of Health, the primary endpoints have been replaced with nine new safety and pharmacodynamic (PD) endpoints.
    • 27 Sep 2023 Status changed from active, no longer recruiting to completed.
    • 29 Jun 2023 Results published in the SK Biosciences Media Release

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top